Hannah Valantine - Director at BridgeBio Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
BBIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Hannah Valantine - trading volume in the past year for BridgeBio Pharma, Inc.

Holdings reported by Hannah Valantine for BridgeBio Pharma, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 3,433 $130 K $37.75 Feb 15, 2024 By Spouse
Common Stock 1,764 $66.6 K $37.75 Feb 15, 2024 Direct
Stock Option (Right to Buy) 26,014 Jun 21, 2024 Direct Common Stock

Transactions reported by Hannah Valantine for BridgeBio Pharma, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership